Current filters:

Memantine HCL

1 to 9 of 59 results

Alzheimer's drug memantine fails to reduce significant agitation


Memantine, a drug prescribed for Alzheimer's disease, does not ease clinically significant agitation…

EbixaMemantine HCLNamendaNeurologicalPharmaceuticalResearch

Combination treatment with memantine and ChEI suggests a comprehensive effect on patients with Alzheimer’s


New data showing that combination therapy with a cholinesterase inhibitor (ChEI) and memantine (Axura,…

donepezilMemantine HCLMerz +NeurologicalPharmaceuticalResearch

Medivation slumps as Alzheimer’s drug candidate Dimebon, partnered with Pfizer, disappoints in Ph III


USA-based Medivation saw its shares price nose dive after it announced, with development partner drug…

AriceptdonepezilEisaiLicensingMemantine HCLNamendaNeurologicalPfizerPharmaceutical

Forest Labs' profit up 8% on AD drug sales


The USA's Forest Laboratories posted an 8% increase in profit for the fiscal second quarter ending September…

Boehringer IngelheimForest LaboratoriesMemantine HCLNamendaSpirivatiotropium

Namenda ER boosts cognitive performance


Patients on Forest Laboratories' once-daily extended-release formulation of Namenda (memantine HCl) experienced…

Forest LaboratoriesMemantine HCLNamenda

1 to 9 of 59 results

Back to top